1 (1) CD013823
GLP-1 Therapies Transforming Obesity Treatment in India Published on 28 Feb, 2025 India's growing obesity burden has accelerated interest in effective treatment options
Because GLP-1 medications lead to weight loss that includes fat and muscle, the skin will lose some of its collagen content, explains board-certified dermatologist Raja Sivamani, MD, MS, AP
10 mg / 2 mL = 5 mg/mL 2.5 mg = 2,500 mcg 2,500 mcg / 5,000 mcg per mL = 0.5 mL = 50 U-100 units Tirzepatide 15 mg vial with 3 mL example A 15 mg tirzepatide vial mixed with 3 mL also gives 5 mg/mL, or 5,000 mcg/mL
I mean, there's just so much we can learn here from the proteomics
It is a cost-effective agent for glycemic control and has been shown in the UKPDS to reduce mortality in obese patients